Open
0%
off list price
Verified licence, no commitment
- Portal access
- Full protocol library
- One-vial minimum
For Clinics
Join the group
Licence-verified ordering, your own branded portal, and a protocol library your team can actually use. No minimum order.
Founding cohort
The first 25 clinics build the evidence base
The first 25 clinics receive Program pricing at Stocking volume for twelve months, in exchange for structured outcome submission — CBPI or LOAD for dogs, AAEP lameness grade plus ultrasound for horses — at baseline, 4, 8 and 12 weeks.
This is the only reason we discount: we are buying the target-species outcome data the field does not yet have. We are not buying volume.
Tiers
Volume-neutral names on purpose. We do not credential clinics, so we do not use words like accredited or centre of excellence.
Stocking
8%
off list price
6+ vials per quarter
- Cold-chain shipping at cost
- Case-support line
Program
15%
off list price
24+ vials per quarter and autoship
- Clinic-branded portal
- Co-branded owner materials
- Shipping waived
- 12-month price lock
Network
22%
off list price
72+ vials per quarter
- Clinic-branded secondary label
- First look on territory
- Quarterly outcome report
Cold chain at cost
$65–$95 per shipment, passed through at cost. Never buried in the vial price, because clinics compare vial prices.
One-vial minimum
Deliberately. A long-shelf-life cryopreserved product costs us almost nothing to ship singly, and cash-thin practices should not have to gamble.
3% quarterly rebate
On spend above your tier floor, credited against the next quarter. One published number, not a negotiation.
Apply
Request clinic access
We verify a veterinary licence before the catalogue and pricing open. That gate is the reason there are no prices on the public pages.
What you get on day one
- Portal access with lot COAs you can hand to a client
- The full protocol library, printable
- Waiting-room posters with your clinic name on them
- A QR check-in link per patient for outcome tracking
- Straight answers about what the evidence does not support
Regulatory status
The cell- and exosome-based products described on this site are not approved by the FDA for use in animals. In the United States they are unapproved new animal drugs. Nothing on this site is a diagnosis, a treatment recommendation, or a substitute for examination by a licensed veterinarian. Product information is directed to veterinary professionals. Pricing and ordering are available only to clinics with a verified licence.